Michael Schlutz practices Oncology. He attended Georgetown University School of Medicine. Georgetown University School of Medicine is ranked 49/84 in Research/PrimaryCare. Dr. Michael J. Schlutz is a published MD. He has 7 papers published. The most current publication "Major activity of cladribine in patients with de novo B-cell prolymphocytic leukemia." He is registered with Medicare.
NPI NUMBER | 1265535256 | |
NPPES Provider LastName | SCHLUTZ | |
NPPES Provider FirstName | MICHAEL | |
NPPES Provider ZIPCode | 926633509 | |
NPPES Provider State | CA | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 231.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1265535256 |
Last Name Of The Provider | SCHLUTZ |
First Name Of The Provider | MICHAEL |
View All |
Dr. Anthony Ciarolla, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Neil M. Barth, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Warren H. Fong, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Khosrow Mahdavi, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Patrick F. Sheehy, MD | |
Dr. Ana M. Rojas, MD |